Skip to main content

Table 3 Proportion of patients in ultrasound remission for the hands only according to different ultrasound remission cut-offs

From: Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission

Patients in DAS28CRP-remission
  All patients (n = 87) csDMARD patients (n = 45) bDMARD patients (n = 42) Difference between treatment groups (p value)
Bilateral wrist and MCP2–5 only
 Ultrasound strict remission 6 (7%) 0 (0%) 6 (14%) 0.009
 Ultrasound semi-strict remission 43 (49%) 23 (51%) 20 (48%) 0.75
 Ultrasound Doppler remission 52 (60%) 27 (60%) 25 (60%) 0.96
  1. Values are given as number of patients and percentage. Comparison between groups by Pearson Chi-Square with p < 0.05 considered significant
  2. Ultrasound strict remission no joints with GS score > 0 and Doppler score > 0, ultrasound semi-strict remission no joints with GS score > 1 and Doppler score > 0, ultrasound Doppler remission no joints with Doppler score, csDMARD conventional synthetic disease-modifying anti-rheumatic drug, bDMARD biological disease-modifying anti-rheumatic drug, MCP metacarpophalangeal joint, GS grey scale